|
PKP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
5.017100E-03 |
| Normal-vs-Stage3 |
6.78699985101616E-10 |
| Normal-vs-Stage4 |
7.54170004224619E-09 |
| Stage1-vs-Stage2 |
3.182800E-01 |
| Stage1-vs-Stage3 |
5.720800E-01 |
| Stage1-vs-Stage4 |
1.115190E-01 |
| Stage2-vs-Stage3 |
5.377200E-01 |
| Stage2-vs-Stage4 |
8.883600E-01 |
| Stage3-vs-Stage4 |
4.326200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
3.704300E-03 |
| Normal-vs-Asian |
1.08489999994799E-06 |
| Caucasian-vs-AfricanAmerican |
5.026200E-01 |
| Caucasian-vs-Asian |
8.856600E-01 |
| AfricanAmerican-vs-Asian |
4.863400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.50760000541916E-08 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.544690E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62525548574877E-12 |
| Normal-vs-Age(61-80Yrs) |
1.51838999999931E-05 |
| Normal-vs-Age(81-100Yrs) |
1.072780E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.685600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.750100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.851000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.317800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.632000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.896200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.117600E-01 |
| Classical-VS-Follicular |
6.5886000000237E-07 |
| Classical-VS-Other |
8.887000E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
6.226900E-04 |
| Tall-VS-Other |
9.920000E-01 |
| Tall-VS-Normal |
7.92219999601329E-08 |
| Follicular-VS-Other |
1.130960E-01 |
| Follicular-VS-Normal |
2.012200E-02 |
| Other-VS-Normal |
5.838000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43139944341897E-11 |
| Normal-vs-N1 |
9.93230000023715E-07 |
| N0-vs-N1 |
5.127200E-01 |
|
|
